Status:
COMPLETED
Automated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
Innovation Fund Denmark
Conditions:
COPD Exacerbation
Hypoxia
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
The aim of the study is to examine if automated oxygen delivery with O2matic is better than manually controlled oxygen therapy for patients admitted to hospital with an exacerbation in Chronic Obstruc...
Detailed Description
Closed-loop control of oxygen therapy is described in the literature used for preterm infants, trauma patients, medical emergency use and patients with COPD. For the latter, closed-loop therapy has be...
Eligibility Criteria
Inclusion
- COPD verified by FEV1/FVC \< 0,70
- Admission due to exacerbation in COPD
- COPD exacerbation and pneumonia can be included
- Duration of admission \> 48 hours
- Need for oxygen supplementation at inclusion (SpO2 \<= 88 % without O2 suppl.)
- Cognitively able to participate in the study
- Willing to participate and give informed consent.
Exclusion
- Need or anticipated need for mechanical ventilation (except intermittent CPAP)
- Major co-morbidities (cancer, heart disease, thromboembolic disease, uncontrolled diabetes)
- Asthma or other respiratory condition requiring higher SpO2 than normal for COPD- patients
- Pregnancy
- Acute thromboembolic disease (\< 2 weeks)
- Cognitive barriers for participation
Key Trial Info
Start Date :
May 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 8 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03464695
Start Date
May 7 2018
End Date
August 8 2018
Last Update
January 8 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Gentofte University Hospital
Hellerup, Denmark, 2900
2
Hvidovre University Hospital
Hvidovre, Denmark, 2650